ARLEVERTAN 20 mg/40 mg Tabletki
Ocena recepty online
Lekarz przeanalizuje Twój przypadek i zdecyduje, czy wystawienie recepty jest medycznie uzasadnione.
Porozmawiaj z lekarzem o tym leku
Omów swoje objawy i opcje leczenia podczas szybkiej konsultacji online.
Jak stosować ARLEVERTAN
Treść ulotki
- ARLEVERTAN 20 mg/40 mg tablets
- Arlevertan may cause drowsiness. If this occurs, you should not drive or operate machinery.
ARLEVERTAN 20 mg/40 mg tablets
cinnarizine/dimenhydrinate
Read this leaflet carefully before you start taking this medicine as it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others, even if their symptoms are the same as yours, as it could be harmful.
- If you get any side effects, even those not listed in this leaflet, tell your doctor, pharmacist or nurse. See section 4.
Contents of this leaflet:
- 1. What Arlevertan is and what it is used for
- 2. What you need to know before you take Arlevertan
- 3. How to take Arlevertan
- 4. Possible side effects
- 5. How to store Arlevertan
- 6. Contents of the pack and other information
1. What is Arlevertan and what is it used for
Arlevertan contains two active ingredients, cinnarizine and dimenhydrinate. The two substances
belong to different groups of medicines. Cinnarizine belongs to the so-called calcium-
antagonists, while dimenhydrinate belongs to the so-called antihistamines.
Both substances work by reducing the symptoms of vertigo (a sensation of dizziness
or spinning) and nausea (feeling unwell). When these two substances are
used in combination, they are more effective than the single application of
each of them.
Arlevertan is used for the treatment of various types of vertigo in adults. Vertigo can
have a number of different causes. The use of Arlevertan can help to carry out daily
activities made difficult by the presence of vertigo.
2. What you need to know before taking Arlevertan
Do not take Arlevertan:
- if you are under 18 years of age
- if you are allergic to cinnarizine, dimenidrinate or diphenhydramine or to any of the other ingredients of this medicine (listed in section 6)
- if you are allergic to any other antihistamine (such as astemizole, chlorpheniramine and terfenadine, used as anti-allergic medicines). You should not take this medicine unless your doctor has prescribed it for you.
- if you have angle-closure glaucoma (a particular type of eye disease)
- if you have epilepsy
- if you have increased pressure inside the brain (e.g. due to a tumor)
- if you have problems with alcohol abuse
- if you have prostate problems that cause difficulty in urination
- if you have liver or kidney failure.
Warnings and precautions
Talk to your doctor or pharmacist before taking Arlevertan if you suffer from:
- hypo- or hypertension
- elevated intraocular pressure
- intestinal obstruction
- enlarged prostate
- hyperthyroidism
- severe heart disease
- Parkinson's disease.
The use of Arlevertan may worsen these conditions. Although Arlevertan may still
be indicated for you, your doctor should be aware of these factors.
Other medicines and Arlevertan
Tell your doctor or pharmacist if you are taking, have recently taken or might
take any other medicines.
Arlevertan can interact with other medicines you are taking.
If taken with the medicines listed below, Arlevertan may cause fatigue or
drowsiness:
- barbiturates (medicines often taken to induce a state of calm)
- narcotic analgesics such as morphine (strong painkillers such as morphine)
- tranquilizers (a type of medicine used to treat depression and anxiety)
- monoamine oxidase inhibitors (used to treat depression and anxiety).
Arlevertan may enhance the effects of the following medicines:
- tricyclic antidepressants (used to treat depression and anxiety)
- atropine (a medicine that relaxes muscles and is often used in eye examinations)
- ephedrine (may be used to treat cough or nasal congestion)
- procarbazine (a medicine used to treat some types of cancer)
- medicines used to lower blood pressure
Aminoglycosides (a type of antibiotic) can damage the inner ear. If you take
Arlevertan, you may not notice this damage.
You should not take Arlevertan with medicines used to correct heart rhythm
problems (antiarrhythmics).
Arlevertan may also alter the skin's response to allergy tests.
Arlevertan with food, drinks and alcohol
Arlevertan may cause indigestion, which can be reduced by taking the tablets after
meals. Do not drink alcohol during treatment with Arlevertan as it may cause fatigue or
drowsiness.
Pregnancy, breastfeeding and fertility
If you are pregnant, suspect you are pregnant or are planning a pregnancy, or if you are
breastfeeding, ask your doctor or pharmacist for advice before taking this
medicine.
Driving and using machines
Arlevertan may cause drowsiness. If this occurs, you should not drive or operate machinery.
3. How to take Arlevertan
Always take Arlevertan exactly as your doctor or pharmacist has instructed. If you have any
doubts, consult your doctor or pharmacist.
The recommended dose is 1 tablet three times a day, to be taken after meals with some
liquid. The tablet must be swallowed whole without being chewed.
Usually, Arlevertan is taken for a maximum of 4 weeks. Your doctor will tell you if it is
necessary to take Arlevertan for longer.
If you take more Arlevertan than you should
Contact a doctor urgently if you have accidentally taken too many tablets or if a
child has ingested any.
Taking too much Arlevertan can cause severe fatigue, lethargy and
instability. The pupils may dilate and you may be unable to urinate. You may experience dry
mouth, flushing of the face, increased heart rate, fever, sweating and
headache.
If you take a massive dose of Arlevertan, you may develop convulsions, hallucinations,
high blood pressure, you may feel shaken, agitated and have difficulty breathing. You may
fall into a coma.
If you forget to take Arlevertan
If you forget to take an Arlevertan tablet, you should skip that dose. Take the
next Arlevertan tablet at the usual time. Do not take a double dose to
make up for a missed tablet.
If you stop taking Arlevertan
Do not stop taking Arlevertan before your doctor tells you to. If
you stop treatment too early, it is likely that the symptoms of dizziness (a feeling of
lightheadedness and spinning) will return.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effectscommon(may affect up to 1 in 10 people): drowsiness, dry mouth,
headache and stomach pain. These are usually mild and disappear within a few
days while continuing treatment with Arlevertan.
Side effectsuncommon(may affect up to 1 in 100 people): sweating,
skin redness, indigestion, nausea (feeling unwell), diarrhoea, nervousness, cramps,
forgetfulness, tinnitus (ringing in the ears), paraesthesia (tingling of hands and/or feet),
tremor.
Side effectsrare(may affect up to 1 in 1000 people): impaired vision,
allergic reactions (e.g. skin reactions), sensitivity to light and difficulty in urination.
Side effectsvery rare(may affect less than 1 in 10,000 people): reduction in the
count of white blood cells and platelets and a significant reduction in the count of red
blood cells, which can cause weakness, bruising or increase the likelihood of developing infections.
If you suffer from infections with fever and a serious worsening of your general health, please
consult your doctor and inform them of the medicines you are taking.
Other possible reactions (frequency cannot be defined based on available data)
that may occur with this type of medicine include:
weight gain, constipation, chest tightness, jaundice (yellowing of the skin or whites
of the eyes due to blood or liver problems), worsening of angle-closure glaucoma (an eye condition with increased eye pressure), uncontrollable movements, unusual excitement and restlessness (especially in children) and severe skin
reactions.
Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your doctor or pharmacist. You can also report side effects directly
through the national reporting system at
www.agenziafarmaco.gov.it/it/responsabili.
By reporting side effects you can help provide more information on the
safety of this medicine.
5. How to store Arlevertan
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the packaging
after EXP. The expiry date refers to the last day of that month.
This medicine does not require any particular storage conditions.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist
how to dispose of medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What Arlevertan contains
The active ingredients are: cinnarizine 20 mg and dimenhydrinate 40 mg.
The other ingredients are: microcrystalline cellulose, corn starch, talc, hypromellose, colloidal
anhydrous silica, magnesium stearate and sodium croscarmellose.
Description of the appearance of Arlevertan and contents of the pack
Arlevertan tablets are round in shape, white in colour and are marked with
an “A”. They are available in packs of 20, 50 or 100 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
HENNIG ARZNEIMITTEL GmbH & Co. KG
Liebigstrasse 1-2, DE-65439 Flörsheim am Main
Germany
For further information on this medicine, contact the local representative of the marketing
authorisation holder:
Licensee:
Polifarma S.p.A.
Viale dell'Arte, 69
- 00144 - Roma Tel. 06227421 Fax 0622742261 e-mail: [email protected]
This medicinal product is authorised in the Member States of the European Economic Area
with the following denominations:
Bulgaria, Czech Republic, Germany, Romania, Slovak Republic: A rlevert
Austria, Luxembourg: Arlevert 20 mg/40 mg Tablets
Belgi o : Arlevertan 20 mg/40 mg comprimés
Denmark, Sweden : Arlevert 20 mg/40 mg tablets
Cyprus: Arlevert 20 mg/40 mg tablet
Estonia: Arlevert 20 mg/40 mg tabletid
Finland: Arlevert 20 mg/40 mg tabletti
Greece: Arlevert 20 mg/40 mg δισκία
Latvia: Arlevert 20 mg/40 mg tablets
Lithuania: Arlevert 20 mg/40 mg tabletės
Hungary: Arlevert tabletta
Ital ia : Arlevertan 20 mg/40 mg compresse
Ireland, United Kingdom : Arlevert 20 mg/40 mg tablets
Pol onia : Arlevert 20 mg + 40 mg tabletki
Portugal: Arlevert 20 mg/40 mg comprimidos
Slovenia: Arlevert 20 mg/40 mg tablet
Spain: Arlevertan 20 mg/40 mg comprimidos
Netherlands : Arlevert 20 mg/40 mg tabletten
Nie jesteś pewien, czy ten lek jest odpowiedni dla ciebie?
Omów swoje objawy i leczenie z lekarzem online.
Zacząłeś przyjmować lek i masz pytania?
Omów swoje objawy i leczenie z lekarzem online.
- Kraj rejestracji
- Postać farmaceutycznaTablet, 20 MG/40 MG
- Kod ATCN07CA52
- Substancja czynna
- Wymaga receptyTak
- Producent
- Te treści mają charakter wyłącznie informacyjny i nie zastępują konsultacji lekarskiej.
- Zamienniki ARLEVERTANPostać farmaceutyczna: Coated tablet, 20 MG/40 MGSubstancja czynna: cinnarizine, combinationsProducent: FARMA GROUP S.R.L.Wymaga receptyPostać farmaceutyczna: Coated tablet, 20 MG/40 MGSubstancja czynna: cinnarizine, combinationsProducent: TORRENT PHARMA (MALTA) LIMITEDBez receptyPostać farmaceutyczna: Coated tablet, 20MG/40MGSubstancja czynna: cinnarizine, combinationsProducent: TECNIGEN S.R.L.Wymaga recepty
Odpowiedniki ARLEVERTAN w innych krajach
Leki z tą samą substancją czynną dostępne w innych krajach.
Odpowiednik ARLEVERTAN w Polska
Odpowiednik ARLEVERTAN w Ukraina
Odpowiednik ARLEVERTAN w Hiszpania
Lekarze online w sprawie ARLEVERTAN
Omów stosowanie ARLEVERTAN, bezpieczeństwo i ocenę zasadności recepty zgodnie z obowiązującymi przepisami.
Uzyskaj receptę na ARLEVERTAN online
Wypełnij 2-minutowy formularz
Opisz swoje objawy, historię choroby i lek, o który prosisz.
Wybierz lekarza lub pozwól nam przydzielić
Wybierz specjalistę lub dopasujemy Cię do najbliższego dostępnego lekarza.
Lekarz analizuje Twój przypadek
Zazwyczaj w ciągu 30 minut. Może zadawać dodatkowe pytania przez czat.
Odbierz w dowolnej aptece
Recepta elektroniczna wysłana na Twój e-mail — ważna w całej Polsce.
Często zadawane pytania
ARLEVERTAN wymaga recepty w Włochy. Możesz skonsultować się z lekarzem online, aby sprawdzić, czy ten lek może być odpowiedni w Twojej sytuacji.
Substancją czynną w ARLEVERTAN jest cinnarizine, combinations. Informacja ta pomaga rozpoznać leki o tym samym składzie, ale pod różnymi nazwami handlowymi.
ARLEVERTAN jest produkowany przez HENNIG ARZNEIMITTEL GMBH & C0. KG. Nazwy handlowe i opakowania mogą się różnić w zależności od dystrybutora.
Lekarze, tacy jak Lekarze rodzinni, Psychiatrzy, Dermatolodzy, Kardiolodzy, Endokrynolodzy, Gastroenterolodzy, Pulmonolodzy, Nefrolodzy, Reumatolodzy, Hematolodzy, Zakaźnicy, Alergolodzy, Geriatrzy, Pediatrzy, Onkolodzy, mogą ocenić, czy stosowanie ARLEVERTAN jest odpowiednie w Twoim przypadku, w zależności od sytuacji klinicznej i lokalnych przepisów. Możesz umówić konsultację online, aby omówić objawy i możliwe dalsze kroki.
Polska posiada dobrze rozwiniętą infrastrukturę ochrony zdrowia w dużych miastach, takich jak Warszawa, Kraków, Wrocław i Gdańsk. Apteki są łatwo dostępne i działają zgodnie z obowiązującymi przepisami, zapewniając dostęp do leków na receptę.
Możesz kupić ARLEVERTAN w Warszawie, Krakowie, Wrocławiu lub Gdańsku w każdej aptece, posiadając ważną receptę.
Aby uzyskać receptę, możesz skorzystać z Oladoctor:
Inne leki zawierające tę samą substancję czynną (cinnarizine, combinations) to m.in. AJIVERT, KINNARITSINA E DIMENIDRINATO TORRENT, ENTSAVER. Mogą one różnić się nazwą handlową lub postacią, ale zawierają ten sam składnik terapeutyczny. Przed zmianą lub rozpoczęciem nowego leku skonsultuj się z lekarzem.
